Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Hamrick SK, Thompson MA, Rotello VM, Prakash YS, Pabelick CM. Nanoparticles to target asthma. Am J Physiol Lung Cell Mol Physiol. 2024 Dec 01; 327(6):L964-L971.
-
Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis. Ann Am Thorac Soc. 2024 Jun; 21(6):866-874.
-
Al-Halbouni L, Ryan GW, Radu S, Spano M, Sabnani R, Phipatanakul W, Gerald LB, Garg A, Pbert L, Trivedi M. Exploring the relationship between school-supervised asthma therapy and social determinants of health in pediatric asthma care. Pediatr Pulmonol. 2024 Oct; 59(10):2553-2562.
-
Chupp G, Murphy KR, Gandhi HN, Gilbert I, Bleecker ER. Asthma control in the United States: Relationships between short-acting ?2-agonist and systemic corticosteroid use. Ann Allergy Asthma Immunol. 2024 Sep; 133(3):302-309.
-
Kolmodin MacDonell K, Bruzzese JM, Dinaj-Koci V, Gibson-Scipio W, Starbird W, Hall A, Dailey R, Jacques-Tiura AJ, Wang B. Predictors of adherence to controller medication in urban African American emerging adults with uncontrolled persistent asthma. J Asthma. 2023 10; 60(10):1877-1884.
-
Akenroye A, Zhou G, Jackson JW, Segal J, Alexander GC, Singh S. Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy. 2023 04; 78(4):1116-1119.
-
Beuther DA, Murphy KR, Zeiger RS, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Chipps B. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. J Allergy Clin Immunol Pract. 2022 Dec; 10(12):3204-3212.e2.
-
Israel E, Cardet JC, Carroll JK, Fuhlbrigge AL, She L, Rockhold FW, Maher NE, Fagan M, Forth VE, Yawn BP, Arias Hernandez P, Kruse JM, Manning BK, Rodriguez-Louis J, Shields JB, Ericson B, Colon-Moya AD, Madison S, Coyne-Beasley T, Hammer GM, Kaplan BM, Rand CS, Robles J, Thompson O, Wechsler ME, Wisnivesky JP, McKee MD, Jariwala SP, Jerschow E, Busse PJ, Kaelber DC, Nazario S, Hernandez ML, Apter AJ, Chang KL, Pinto-Plata V, Stranges PM, Hurley LP, Trevor J, Casale TB, Chupp G, Riley IL, Shenoy K, Pasarica M, Calderon-Candelario RA, Tapp H, Baydur A, Pace WD. Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma. N Engl J Med. 2022 04 21; 386(16):1505-1518.
-
Chipps BE, Murphy KR, Oppenheimer J. 2020 NAEPP Guidelines Update and GINA 2021-Asthma Care Differences, Overlap, and Challenges. J Allergy Clin Immunol Pract. 2022 01; 10(1S):S19-S30.
-
Murphy KR, Solis J. National Asthma Education and Prevention Program 2020 Guidelines: What's Important for Primary Care. J Fam Pract. 2021 07; 70(6S):S19-S28.